Medicinal product name Amitriptyline-Grindeks 25 mg apvalkotās tabletes
Pharmaceutical form Film-coated tablet
Strength 25 mg 
Information from the MAH on shortages No information on expected shortages
Availability of medicinal product
Product No.Package sizeWholesalers' stock state
99-0092-01 KZSRN50 Is available
Legal status Rx Prescription (Pr.)
KZSR Reimbursed medicines reference product
Package leaflet MS Word document 31-01-2019
Summary of product characteristics MS Word document 31-01-2019
ATC code N06AA09 Psychoanaleptics

Important notice

Additional information regarding the use for persons aged 75+

If used as "PSYCHOANALEPTICS"
SubstanceClassComment
Amitriptylini hydrochloridumDAvoid use in older persons. Anticholinergic. Sedative. Serotonergic. Risk of QT prolongation. Low doses (10-20mg) can be used for treating neuropathic pain. Significant adverse effects include confusion, cognitive disorder, tremor, arrhytmia, tachycardia, orthostatic hypotension and serotonin syndrome. Increases risk for falls. Take several interactions into account. Weakens the efficacy of anti-Alzheimer´s drugs.

Medicinal products (1)

Availability of medicinal product Wholesalers Package size, content Primary packaging Maximum admissible pharmacy price (€ incl. VAT) Product No. Labelling
 Is available (according to the information provided by wholesalers)
(30899 containers)
Grindeks, Laurus MED, Magnum Medical, Olainfarm, Recipe Plus, Tamro, Euroaptieka, Jelgavfarm, Oribalt Rīga, Medelens+ N50
(25 mg)
PVC/Al blister 1.57 
KZSR*
99-0092-01 Labelling text Labelling text Jan 31, 2019
* Indication about medicine on the List of state reimbursed medicines is just informative. Source of the information is the National Health Service. For details please visit the NHS website.

Registration information

Marketing authorisation No. 99-0092
Date of authorisation Jan 20, 1999
MA valid until For unlimited time
Marketing authorisation holder, country Grindeks, AS, Latvia